The Organization of Pharmaceutical producers of India, which representsthe Indian subsidiaries of foreign pharmaceutical companies and major local manufacturers, has urged the Indian government to institute strong intellectual property protection to encourage foreign investment in the pharmaceutical sector, and curtail the current brain drain from India.
OPPI has told the federal Ministry of Chemicals and Fertilizers that strong intellectual property rights will be instrumental in reversing this process, not only boosting the confidence of foreign investors but also putting a halt to the "world-renowned pool of scientific talent" moving out of the country.
Many multinational companies will be reluctant to introduce innovative new medicines in the absence of strong IPP, said OPPI's president, Mr D Bhadury. Only a strong patent law can encourage, stimulate and sustain innovation, he said, adding: "it appears that basically we have not developed the mindset to accept the fact of globalization and appreciate the reality that India cannot afford to stand isolated when its economy is globalizing."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze